Similar articles for PMID: 31732674

Year	Number of Results
1980	1
1981	1
1983	1
1985	1
1991	1
1996	1
1998	1
1999	2
2001	1
2002	2
2003	2
2004	1
2005	3
2006	3
2007	1
2008	6
2009	3
2010	1
2011	6
2012	7
2013	10
2014	7
2015	4
2016	8
2017	6
2018	9
2019	5
2020	8
2021	5
2022	9
2023	2
2024	0

1

Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer.

Kumar M, Salem K, Tevaarwerk AJ, Strigel RM, Fowler AM. Kumar M, et al. J Nucl Med. 2020 Feb;61(2):172-176. doi: 10.2967/jnumed.119.228858. Epub 2019 Nov 15. J Nucl Med. 2020. PMID: 31732674 Free PMC article. Review.

2

Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.

Yoon HJ, Kang KW, Chun IK, Cho N, Im SA, Jeong S, Lee S, Jung KC, Lee YS, Jeong JM, Lee DS, Chung JK, Moon WK. Yoon HJ, et al. Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1534-43. doi: 10.1007/s00259-014-2744-4. Epub 2014 Mar 21. Eur J Nucl Med Mol Imaging. 2014. PMID: 24652232

3

[Steroid receptors and breast carcinoma].

Pasić R, Dulbegović B, Softić D, Wittlif JL. Pasić R, et al. Med Pregl. 1991;44(1-2):48-51. Med Pregl. 1991. PMID: 1870463 Review. Croatian.

4

Estrogen and progesterone receptors in breast cancer.

Yip CH, Rhodes A. Yip CH, et al. Future Oncol. 2014 Nov;10(14):2293-301. doi: 10.2217/fon.14.110. Future Oncol. 2014. PMID: 25471040 Review.

5

Clinical Potential of Estrogen and Progesterone Receptor Imaging.

Linden HM, Peterson LM, Fowler AM. Linden HM, et al. PET Clin. 2018 Jul;13(3):415-422. doi: 10.1016/j.cpet.2018.02.005. PET Clin. 2018. PMID: 30100079 Free PMC article. Review.

6

The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[¹⁸F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Katzenellenbogen JA. Katzenellenbogen JA. Nucl Med Biol. 2021 Jan;92:24-37. doi: 10.1016/j.nucmedbio.2020.02.007. Epub 2020 Feb 22. Nucl Med Biol. 2021. PMID: 32229068 Free PMC article. Review.

7

Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.

Brouckaert O, Pintens S, Van Belle V, Van Huffel S, Camerlynck E, Amant F, Leunen K, Smeets A, Berteloot P, Van Limbergen E, Decock J, Hendrickx W, Weltens C, Van den Bogaert W, Vanden Bempt I, Drijkoningen M, Paridaens R, Wildiers H, Vergote I, Christiaens MR, Neven P. Brouckaert O, et al. Breast Cancer Res Treat. 2009 May;115(2):349-58. doi: 10.1007/s10549-008-0110-6. Epub 2008 Jul 16. Breast Cancer Res Treat. 2009. PMID: 18629635 Clinical Trial.

8

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.

Cui X, Schiff R, Arpino G, Osborne CK, Lee AV. Cui X, et al. J Clin Oncol. 2005 Oct 20;23(30):7721-35. doi: 10.1200/JCO.2005.09.004. J Clin Oncol. 2005. PMID: 16234531 Review.

9

Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer.

Young PC, Ehrlich CE, Einhorn LH. Young PC, et al. Cancer. 1980 Dec 15;46(12 Suppl):2961-3. doi: 10.1002/1097-0142(19801215)46:12+<2961::aid-cncr2820461444>3.0.co;2-e. Cancer. 1980. PMID: 7448744

10

Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.

Kim HJ, Cui X, Hilsenbeck SG, Lee AV. Kim HJ, et al. Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1013s-1018s. doi: 10.1158/1078-0432.CCR-05-2128. Clin Cancer Res. 2006. PMID: 16467118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year